The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activity

Samantha L. Grimes(Vanderbilt University Medical Center), Jordan Anderson-Daniels(Vanderbilt University Medical Center), Brook E. Heaton(Duke University), Katie Burke(Duke University), Mackenzie L. Anderson(Duke University), Laura J. Stevens(Vanderbilt University Medical Center), Xiaotao Lu(Vanderbilt University Medical Center), Nicholas S. Heaton(Duke University), Mark R. Denison(Vanderbilt Health)
Journal of Virology
January 10, 2025
10.1128/jvi.01708-24
Cited by 9

Related Papers

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
|Nature|2020|1.7k
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
|mBio|2018|1.5k
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
|Science Translational Medicine|2020|1.2k
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
|Cell Reports|2020|541
Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome Sequencing
|PLoS Pathogens|2010|529